Pages that link to "Q41955446"
Jump to navigation
Jump to search
The following pages link to Recent Developments in Sterol 14-demethylase Inhibitors for Chagas Disease. (Q41955446):
Displaying 36 items.
- Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease (Q24597322) (← links)
- VNI cures acute and chronic experimental Chagas disease (Q24604994) (← links)
- Translational challenges of animal models in Chagas disease drug development: a review (Q26796451) (← links)
- The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection (Q26829884) (← links)
- Rational Development of 4-Aminopyridyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51 as Anti-Chagas Agents (Q27680103) (← links)
- Expanding the Binding Envelope of CYP51 Inhibitors TargetingTrypanosoma cruziwith 4-Aminopyridyl-Based Sulfonamide Derivatives (Q27683570) (← links)
- Squalene synthase as a target for Chagas disease therapeutics (Q27683611) (← links)
- R -Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi (Q27684247) (← links)
- 4-Aminopyridyl-Based CYP51 Inhibitors as Anti- Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency (Q27684956) (← links)
- Soulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunction (Q28536088) (← links)
- Genetic profiling of the isoprenoid and sterol biosynthesis pathway genes of Trypanosoma cruzi (Q28538787) (← links)
- Madurella mycetomatis is highly susceptible to ravuconazole (Q28539848) (← links)
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease (Q28548320) (← links)
- SQ109, a new drug lead for Chagas disease (Q30626912) (← links)
- Drug strategies targeting CYP51 in neglected tropical diseases (Q34622554) (← links)
- Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51. (Q34701325) (← links)
- Discovery of new uncompetitive inhibitors of glucose-6-phosphate dehydrogenase (Q35224409) (← links)
- Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii. (Q35660950) (← links)
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development (Q37732551) (← links)
- Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives (Q38256874) (← links)
- Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis (Q38364470) (← links)
- Clotrimazole as a Cancer Drug: A Short Review (Q38714666) (← links)
- Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive Yeast (Q38782578) (← links)
- Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015). (Q38845466) (← links)
- Assessing anti-T. cruzi candidates in vitro for sterile cidality (Q38929035) (← links)
- Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii. (Q38938937) (← links)
- Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection (Q39508383) (← links)
- Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease (Q41073713) (← links)
- Experimental and Clinical Treatment of Chagas Disease: A Review. (Q41989175) (← links)
- Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole (Q47115930) (← links)
- The long road towards a safe and effective treatment of chronic Chagas disease (Q49905041) (← links)
- CYP51 as drug targets for fungi and protozoan parasites: past, present and future. (Q52593361) (← links)
- Rational Selection of Anti-Microbial Drug Targets: Unique or Conserved? (Q58850854) (← links)
- Structure, Properties, and Function of Glycosomes in Trypanosoma cruzi (Q89823561) (← links)
- Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi (Q91941849) (← links)
- Potent and selective inhibitors for M32 metallocarboxypeptidases identified from high-throughput screening of anti-kinetoplastid chemical boxes (Q92072825) (← links)